Latest filing published 23 Feb 2017 for Achaogen, Inc., €22k.
Filing timeline
BuySaleInsider track record
Ian Friedland: trading record in brief
Ian Friedland discloses dealings in Achaogen, Inc. to SEC (Form 4). Between 5 February 2015 and 21 February 2017, the trades on record add up to 5 filings.
Sales make up the whole of the open-market record (3 sales, €38k). Outside the open market, there are 2 share grants. Since January 2017: no purchases and 2 sales on the market.
The latest filing, published on 23 February 2017, reports an open-market sale of €22k in Achaogen, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Ian Friedland
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,026 shares@ US$22.7658.0% of flowCommon StockSEC:0001140361-17-008926:0
- 695 shares@ US$16.7828.6% of flowCommon StockSEC:0001140361-17-003548:0
- 1,772 shares@ US$3.2213.4% of flowCommon StockSEC:0001140361-16-058612:0
- 13,500 shares0Common StockSEC:0001140361-16-055795:0
- 15,000 shares0Common StockSEC:0001140361-15-004967:0
5 of 5 declarations
